Company / Income Tax per Share
BeOne Medicines Ltd. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.09
FY2025
5-year range
$0.02 / $0.09
FY2021-FY2025
Trend
+13.9%
vs FY2024
Sector context
#45 of 201
Health Care
What the data says
BeOne Medicines Ltd.'s income tax per share of $0.09 is higher than 78% of companies in the Health Care sector (FY2025). Income Tax per Share has increased for 7 consecutive years, from $-0.03 in FY2018 to $0.09 in FY2025.
Based on SEC 10-K filings.
0.09 in FY2025 with a 5-year CAGR of +48.5%. Top quartile in the Health Care sector.
Increased from $0.04 to $0.09 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +43.0%
- 5-Year CAGR
- +48.5%
- 10-Year CAGR
- -
Sector benchmark
-93.1% below sector average
Key checks
Key Insights
- BeOne Medicines Ltd.'s income tax per share has grown for 7 consecutive years.
- In FY2025, income tax per share increased 13.9% year-over-year.
- Ranks #45 out of 201 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | +13.9% |
| FY2024 | $0.08 | +99.6% |
| FY2023 | $0.04 | +28.6% |
| FY2022 | $0.03 | +101.0% |
| FY2021 | $0.02 | +22.9% |
| FY2020 | $0.01 | +44.0% |
| FY2019 | $0.01 | +133.8% |
| FY2018 | -$0.03 | -715.8% |
| FY2017 | $0.00 | +832.1% |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026